Skip to main content
. Author manuscript; available in PMC: 2010 Feb 1.
Published in final edited form as: Stroke. 2008 Dec 18;40(2):505–509. doi: 10.1161/STROKEAHA.108.528281

Table 3.

Unadjusted comparison of endpoints between patients randomized to aspirin vs. warfarin

aspirin warfarin Hazard Ratio (aspirin/warfarin) (95% CI) p- value
Patients ON antithrombotic at time of qualifying event N = 126 N = 134
 Stroke or vascular death No. patients (%) 29 (23%) 24 (18%) 1.32 (0.77–2.28) 0.31
 Ischemic stroke in territory No. patients (%) 21 (17%) 12 (9%) 1.92 (0.95–3.91) 0.07
Patients OFF antithrombotic at time of qualifying event N = 137 N = 132
 Stroke or vascular death No. patients (%) 27 (20%) 34 (26%) 0.75 (0.45–1.25) 0.27
 Ischemic stroke in territory No. patients (%) 18 (13%) 20 (15%) 0.85 (0.45–1.61) 0.62